Algert Global LLC Boosts Stock Holdings in Aspen Aerogels, Inc. (NYSE:ASPN)

Algert Global LLC raised its holdings in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 60.2% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 127,764 shares of the construction company's stock after acquiring an additional 48,007 shares during the quarter. Algert Global LLC owned approximately 0.17% of Aspen Aerogels worth $3,538,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Point72 Hong Kong Ltd bought a new stake in shares of Aspen Aerogels in the 2nd quarter valued at $84,000. nVerses Capital LLC bought a new stake in shares of Aspen Aerogels in the 2nd quarter valued at $95,000. Quent Capital LLC bought a new stake in shares of Aspen Aerogels in the 3rd quarter valued at $118,000. Point72 DIFC Ltd bought a new position in Aspen Aerogels during the second quarter worth $121,000. Finally, Public Employees Retirement Association of Colorado bought a new position in Aspen Aerogels during the second quarter worth $145,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, CEO Donald R. Young sold 63,355 shares of the firm's stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now owns 483,640 shares in the company, valued at approximately $14,523,709.20. This trade represents a 11.58 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 4.30% of the stock is currently owned by corporate insiders.

Aspen Aerogels Stock Down 4.7 %

Shares of ASPN stock traded down $0.71 on Tuesday, hitting $14.34. The stock had a trading volume of 1,871,638 shares, compared to its average volume of 1,634,570. The business has a 50 day moving average of $20.88 and a 200 day moving average of $24.23. The stock has a market cap of $1.18 billion, a price-to-earnings ratio of 1,424.00 and a beta of 2.21. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. Aspen Aerogels, Inc. has a 12-month low of $10.31 and a 12-month high of $33.15.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on ASPN. Roth Mkm cut their target price on shares of Aspen Aerogels from $36.00 to $31.00 and set a "buy" rating on the stock in a research note on Friday, November 8th. TD Cowen raised their price objective on shares of Aspen Aerogels from $36.00 to $41.00 and gave the company a "buy" rating in a research note on Tuesday, August 20th. HC Wainwright reaffirmed a "buy" rating and issued a $30.00 price objective on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Benchmark reaffirmed a "buy" rating and issued a $14.00 price objective on shares of Aspen Aerogels in a research note on Thursday, August 8th. Finally, Piper Sandler dropped their price objective on shares of Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating on the stock in a research note on Tuesday, October 22nd. One analyst has rated the stock with a sell rating, nine have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Aspen Aerogels has a consensus rating of "Moderate Buy" and an average target price of $28.70.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.